Custom-designed polymers open new path to electrochemical separations for sustainable drug manufacturing

Enantiomers, or molecule pairs that are mirror images of each other, make up more than half of FDA-approved drugs in use today, including those used in treatments for cancer, neurologic diseases and arthritis. Separating enantiomers is critical for drug manufacturing because the effect of each molecule in the pair can be very different—for example, one enantiomer might cure a headache while its mirror-image could cause a headache.